← Back
Data updated: Jul 17, 2026
CEPH INTL
Generics Pharmaceuticals
CEPH INTL is a generic drug manufacturer with 1 FDA-approved products.
1979
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
CEPH INTL's Key Drugs
CEPH INTL's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
CEPH INTL's Recent FDA Approvals
New NDA/BLA approvals for CEPH INTL over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
CEPH INTL's Therapeutic Areas
Disease areas where CEPH INTL has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
CEPH INTL Pipeline Snapshot
Active clinical trials for CEPH INTL across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1979-07-28
- Latest
- 2000-05-01
- Applications
- 1